Liang Huang

399 Ling Ling Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study.

The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study.

Journal: International journal of clinical oncology

Published: July 25, 2025

Breast cancer: pathogenesis and treatments.

Breast cancer: pathogenesis and treatments.

Journal: Signal transduction and targeted therapy

Published: July 21, 2024

Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.

Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.

Journal: Nature communications

Published: July 13, 2023

Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial.

Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial.

Journal: Cancer biology & medicine

Published: July 21, 2022

Using relative-speed-of-processing to explain the shielding function of task rules.

Using relative-speed-of-processing to explain the shielding function of task rules.

Journal: Quarterly journal of experimental psychology (2006)

Published: December 14, 2021

A predictor of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients with the DNA repair genes.

A predictor of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients with the DNA repair genes.

Journal: Annals of translational medicine

Published: March 12, 2021

Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk.

Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk.

Journal: Annals of translational medicine

Published: December 14, 2020

Insights Into the Impacts of BRCA Mutations on Clinicopathology and Management of Early-Onset Triple-Negative Breast Cancer.

Insights Into the Impacts of BRCA Mutations on Clinicopathology and Management of Early-Onset Triple-Negative Breast Cancer.

Journal: Frontiers in oncology

Published: June 21, 2020

eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancer.

eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancer.

Journal: Annals of translational medicine

Published: February 12, 2020

Time for a true display of skill: Top players in League of Legends have better executive control.

Time for a true display of skill: Top players in League of Legends have better executive control.

Journal: Acta psychologica

Published: August 20, 2019

Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.

Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.

Journal: Cancer medicine

Published: August 11, 2019

Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer.

Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer.

Journal: Cancer chemotherapy and pharmacology

Published: August 11, 2019

Showing 1-12 of 30

Last Updated: 09/26/2026